Ibio Inc
NASDAQ:IBIO

Watchlist Manager
Ibio Inc Logo
Ibio Inc
NASDAQ:IBIO
Watchlist
Price: 1.98 USD 5.32% Market Closed
Market Cap: 74.8m USD

Wall Street
Price Targets

IBIO Price Targets Summary
Ibio Inc

Wall Street analysts forecast IBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IBIO is 4.49 USD with a low forecast of 1.62 USD and a high forecast of 6.3 USD.

Lowest
Price Target
1.62 USD
18% Downside
Average
Price Target
4.49 USD
127% Upside
Highest
Price Target
6.3 USD
218% Upside
Ibio Inc Competitors:
Price Targets
ARGX
argenx SE
17% Upside
VNDA
Vanda Pharmaceuticals Inc
75% Upside
REGN
Regeneron Pharmaceuticals Inc
3% Upside
SCLP
Scancell Holdings PLC
224% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
VITR
Vitrolife AB
38% Upside
BIOCON
Biocon Ltd
11% Upside
688278
Xiamen Amoytop Biotech Co Ltd
20% Upside

Revenue
Forecast

Revenue Estimate
Ibio Inc

For the last 13 years the compound annual growth rate for Ibio Inc's revenue is -9%. The projected CAGR for the next 3 years is -14%.

-9%
Past Growth
-14%
Estimated Growth
Estimates Accuracy
61%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ibio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Ibio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-98%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IBIO's stock price target?
Price Target
4.49 USD

According to Wall Street analysts, the average 1-year price target for IBIO is 4.49 USD with a low forecast of 1.62 USD and a high forecast of 6.3 USD.

What is Ibio Inc's Revenue forecast?
Projected CAGR
-14%

For the last 13 years the compound annual growth rate for Ibio Inc's revenue is -9%. The projected CAGR for the next 3 years is -14%.

Back to Top